Common problems with antiretroviral therapy among three Swedish groups of HIV infected individuals

Author： Jallow Amadou   Sporrong Sofia   Walther-Jallow Lilian   Persson Peter   Hellgren Urban   Ericsson Örjan  

Publisher： Springer Publishing Company

ISSN： 0928-1231

Source： Pharmacy World and Science, Vol.29, Iss.4, 2007-08, pp. : 422-429

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolic complications of antiretroviral therapy in HIV-infected children

By Eley Brian  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 1, 2008-01 ,pp. : 37-49

Informa Healthcare

Access to resources Recommend Favorite

Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients

By Harris Marianne  

Expert Opinion on Drug Safety, Vol. 7, Iss. 4, 2008-07 ,pp. : 389-400

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of Antiretroviral Therapy in HIV-1-Infected Children

By Fraaij Pieter L.A.   van Kampen Jeroen J.A.   Burger David M.   Ronald de Groot  

Clinical Pharmacokinetics, Vol. 44, Iss. 9, 2005-01 ,pp. : 935-956

Adis International

Access to resources Recommend Favorite

Effects of Antiretroviral Therapy on Immunity in Patients Infected with HIV

By  

Current Pharmaceutical Design, Vol. 12, Iss. 9, 2006-03 ,pp. : 1015-1022

Bentham Science Publishers

Access to resources Recommend Favorite

Cost-Efficacy Comparison among Three Antiretroviral Regimens in HIV-1 Infected, Treatment-Experienced Patients

By Ruof Jörg  

Clinical Drug Investigation, Vol. 27, Iss. 7, 2007-01 ,pp. : 469-479

Adis International

Access to resources Recommend Favorite